|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/16 | |
| A61K 48/00 | |||
| C12N 15/86 | |||
| A61P 1/16 | |||
| A61P 3/06 | |||
| A61P 3/08 | |||
| A61P 3/10 | |||
| A61P 13/12 | |||
| A61P 19/06 |
| (11) | Number of the document | 3415620 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18186594.0 |
| Date of filing the European patent application | 2014-11-25 | |
| (97) | Date of publication of the European application | 2018-12-19 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361908861 P | 2013-11-26 | US |
| (72) |
CHOU, Janice, J., US
|
| (73) |
The United States of America, as represented by The Secretary, Department of Health and Human Services,
National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20852-7660,
US
|
| (54) | ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE |
| ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE |